EUVIMEDEUVIMED entdecken
Crossref

Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21

Chengcheng Wang, Yapeng Wang, Yuanzhen Dong, Yu Duan, Ying Zhang, Hao Huang, Zhiru Xu, Jianguang Lu, Chunyong Ding iD, Zhengyan Cai, Dianwen Ju iD, Jun Feng iD

Bioconjugate Chemistry · 2025

DOI: 10.1021/acs.bioconjchem.4c00549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2025. Verfasst von Chengcheng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmace…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Fatty Acids, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Shanghai Duomirui Bio-tech Co., Ltd., National Key Laboratory of Lead Druggability Research, China State Institute of Pharmaceutical Industry Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast growth factor 21 (FGF21) is a crucial regulator of glucose and lipid metabolism, showing significant therapeutic promise for metabolic disorders. However, its clinical application is limited by poor pharmacokinetics. One potential strategy to improve its half-life is to facilitate albumin binding through fatty acid derivation. Despite this promise, achieving site-specific modifications of FGF21 while preserving its biological activity has been challenging. In this study, we applied a rational design approach to create site-specific fatty acid derivatives of FGF21, guided by the structure of the FGF21-receptor complex. This strategy successfully enhances albumin binding without interfering with receptor interactions. The modified FGF21 derivatives exhibited dramatically extended half-lives in mice, increasing from 0.73 h to 11.36 and 13.36 h, respectively. Furthermore, these analogues showed superior biological activity in the presence of albumin, outperforming the C-terminal-derived variant zalfermin. This rational design approach not only improves the pharmacokinetic profile of FGF21 but also provides a framework for enhancing the therapeutic potential of other small proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsFatty AcidsDrug DesignAnimalsHalf-LifeMiceHumansMale

Substanzen

Fibroblast Growth FactorsFatty Acidsfibroblast growth factor 21

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of Drug Target Identification and Delivery, National Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, 200240 Shanghai, China.
  • National Key Laboratory of Lead Druggability Research, China State Institute of Pharmaceutical Industry Co., Ltd., 201203 Shanghai, China.
  • Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, 201203 Shanghai, China.
  • Shanghai Duomirui Bio-tech Co., Ltd., 201203 Shanghai, China.
  • Center for Pharmacological Evaluation and Research, Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry Co., Ltd., 200083 Shanghai, China.

ORCID-Profile: Chunyong Ding, Dianwen Ju, Jun Feng

Förderung

  • Shanghai Duomirui Bio-tech Co., Ltd.
  • National Key Laboratory of Lead Druggability Research, China State Institute of Pharmaceutical Industry Co., Ltd.

Zitieren

APA

Wang, C., Wang, Y., Dong, Y., Duan, Y., Zhang, Y., Huang, H., Xu, Z., Lu, J., Ding, C., Cai, Z., Ju, D., & Feng, J. (2025). Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.4c00549

Vancouver

Wang C, Wang Y, Dong Y, Duan Y, Zhang Y, Huang H, et al. Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21. Bioconjugate Chemistry. 2025. doi:10.1021/acs.bioconjchem.4c00549

BibTeX
@article{Wang2025,
  author = {Wang, Chengcheng and Wang, Yapeng and Dong, Yuanzhen and Duan, Yu and Zhang, Ying and Huang, Hao and Xu, Zhiru and Lu, Jianguang and Ding, Chunyong and Cai, Zhengyan and Ju, Dianwen and Feng, Jun},
  title = {Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21},
  journal = {Bioconjugate Chemistry},
  year = {2025},
  doi = {10.1021/acs.bioconjchem.4c00549}
}
Kostenlos starten →